Dr. Plevritis Selected for National Cancer Institute Board of Scientific Advisors

March 13, 2017

Sylvia K. Plevritis, PhD, has been selected for the National Cancer Institute Board of Scientific Advisors. The Board consists of up to 35 members, including the Chair, knowledgeable in their respective fields with emphasis on training and experience in various disciplines and fields. The Board makes recommendations on research priorities conducted or supported by the Institute. This includes the evaluation of NCI awarded grants, cooperative agreements and contracts and concept review of those activities which it considers meritorious and consistent with the Institute's programs. The advisory role of the Board is scientific and does not include deliberation on matters of public policy. Meetings of the full Board will be held approximately 3 times within a fiscal year.

Congratulations, Dr. Plevritis!